Neurokinin Receptors and Their Implications in Various Autoimmune Diseases

Overview

Journal Curr Res Immunol

Specialty Allergy & Immunology

Date 2022 May 2

PMID 35492389

Authors

Amrita Mishra

Girdhari Lal

Affiliations

Soon will be listed here.

Abstract

Neurokinin receptors belong to the GPCRs family and are ubiquitously expressed throughout the nervous and immune systems. Neurokinin receptors in coordination with neurokinins playing an important role in many physiological processes, including smooth muscle contraction, secretion, proliferation, and nociception. They also contribute to various disease conditions such as inflammatory bowel disease, rheumatoid arthritis, multiple sclerosis, psoriasis, and cancer. Neurokinin receptors antagonist are potent and highly selective and showing success in treating chemotherapy-induced nausea and vomiting. In this review, discuss the various neurokinin receptor expression on immune cells and their importance in various inflammatory and autoimmune diseases and their therapeutic importance.

Citing Articles

Reduction of Prostate Cancer Risk: Role of Frequent Ejaculation-Associated Mechanisms.

Hassan M, Flanagan T, Eshaq A, Altamimi O, Altalag H, Alsharif M Cancers (Basel). 2025; 17(5).

PMID: 40075690 PMC: 11898507. DOI: 10.3390/cancers17050843.

Alternative Splicing at the Crossroad of Inflammatory Bowel Diseases and Colitis-Associated Colon Cancer.

Matos P, Jordan P Cancers (Basel). 2025; 17(2).

PMID: 39858001 PMC: 11764256. DOI: 10.3390/cancers17020219.

Neurokinin-2 receptor negatively modulates substance P responses by forming complex with Neurokinin-1 receptor.

Nguyen L, Cho M, Nguyen T, Park H, Nguyen H, Mykhailova K Cell Biosci. 2023; 13(1):212.

PMID: 37968728 PMC: 10652611. DOI: 10.1186/s13578-023-01165-6.

Hemokinin-1 induces transcriptomic alterations in pain-related signaling processes in rat primary sensory neurons independent of NK1 tachykinin receptor activation.

Takacs-Lovasz K, Aczel T, Borbely E, Szoke E, Czuni L, Urban P Front Mol Neurosci. 2023; 16:1186279.

PMID: 37965042 PMC: 10641776. DOI: 10.3389/fnmol.2023.1186279.

Nociceptor-Macrophage Interactions in Apical Periodontitis: How Biomolecules Link Inflammation with Pain.

Menon N, Kishen A Biomolecules. 2023; 13(8).

PMID: 37627258 PMC: 10452348. DOI: 10.3390/biom13081193.

References

Asadi S, Alysandratos K, Angelidou A, Miniati A, Sismanopoulos N, Vasiadi M . Substance P (SP) induces expression of functional corticotropin-releasing hormone receptor-1 (CRHR-1) in human mast cells. J Invest Dermatol. 2011; 132(2):324-9. PMC: 3471564. DOI: 10.1038/jid.2011.334. View

Page N, Woods R, Gardiner S, Lomthaisong K, Gladwell R, Butlin D . Excessive placental secretion of neurokinin B during the third trimester causes pre-eclampsia. Nature. 2000; 405(6788):797-800. DOI: 10.1038/35015579. View

Fu W, Qin B, Zhou A, Yu Q, Huang Q, Liang Z . Regulation of NK92-MI cell cytotoxicity by substance P. Scand J Immunol. 2011; 74(2):107-13. DOI: 10.1111/j.1365-3083.2011.02550.x. View

Barbosa-Cobos R, Lugo-Zamudio G, Flores-Estrada J, Becerril-Mendoza L, Rodriguez-Henriquez P, Torres-Gonzalez R . Serum substance P: an indicator of disease activity and subclinical inflammation in rheumatoid arthritis. Clin Rheumatol. 2017; 37(4):901-908. DOI: 10.1007/s10067-017-3929-6. View

Wang X, Douglas S, Lai J, Tuluc F, Tebas P, Ho W . Neurokinin-1 receptor antagonist (aprepitant) inhibits drug-resistant HIV-1 infection of macrophages in vitro. J Neuroimmune Pharmacol. 2007; 2(1):42-8. DOI: 10.1007/s11481-006-9059-6. View

Pincelli C, Fantini F, Magnoni C, Giannetti A . Psoriasis and the nervous system. Acta Derm Venereol Suppl (Stockh). 1994; 186:60-1. View

Krause J, Chirgwin J, Carter M, Xu Z, HERSHEY A . Three rat preprotachykinin mRNAs encode the neuropeptides substance P and neurokinin A. Proc Natl Acad Sci U S A. 1987; 84(3):881-5. PMC: 304320. DOI: 10.1073/pnas.84.3.881. View

Kotani H, Hoshimaru M, Nawa H, Nakanishi S . Structure and gene organization of bovine neuromedin K precursor. Proc Natl Acad Sci U S A. 1986; 83(18):7074-8. PMC: 386655. DOI: 10.1073/pnas.83.18.7074. View

Castagliuolo I, Valenick L, Liu J, Pothoulakis C . Epidermal growth factor receptor transactivation mediates substance P-induced mitogenic responses in U-373 MG cells. J Biol Chem. 2000; 275(34):26545-50. DOI: 10.1074/jbc.M003990200. View

10.

Zakko S, Barton G, Weber E, Dunger-Baldauf C, Ruhl A . Randomised clinical trial: the clinical effects of a novel neurokinin receptor antagonist, DNK333, in women with diarrhoea-predominant irritable bowel syndrome. Aliment Pharmacol Ther. 2011; 33(12):1311-21. DOI: 10.1111/j.1365-2036.2011.04656.x. View

11.

Munoz M, Carranza A, Pavon A, Anderson G, Covenas R . Immunolocalization of substance P and NK-1 receptor in Hofbauer cells in human normal placenta. Microsc Res Tech. 2013; 76(12):1310-3. DOI: 10.1002/jemt.22303. View

12.

Yu M, Lee S, Lee H, Amouzegar A, Nakao T, Chen Y . Neurokinin-1 Receptor Antagonism Ameliorates Dry Eye Disease by Inhibiting Antigen-Presenting Cell Maturation and T Helper 17 Cell Activation. Am J Pathol. 2019; 190(1):125-133. PMC: 6943374. DOI: 10.1016/j.ajpath.2019.09.020. View

13.

Vigna S . Phosphorylation and desensitization of neurokinin-1 receptor expressed in epithelial cells. J Neurochem. 1999; 73(5):1925-32. View

14.

Blum A, Setiawan T, Hang L, Stoyanoff K, Weinstock J . Interleukin-12 (IL-12) and IL-23 induction of substance p synthesis in murine T cells and macrophages is subject to IL-10 and transforming growth factor beta regulation. Infect Immun. 2008; 76(8):3651-6. PMC: 2493212. DOI: 10.1128/IAI.00358-08. View

15.

Navari R . Fosaprepitant: a neurokinin-1 receptor antagonist for the prevention of chemotherapy-induced nausea and vomiting. Expert Rev Anticancer Ther. 2008; 8(11):1733-42. DOI: 10.1586/14737140.8.11.1733. View

16.

Khan M, Douglas S, Benton T . Substance P-neurokinin-1 receptor interaction upregulates monocyte tissue factor. J Neuroimmunol. 2011; 242(1-2):1-8. PMC: 3278501. DOI: 10.1016/j.jneuroim.2011.10.012. View

17.

Lang K, Drell T, Niggemann B, Zanker K, Entschladen F . Neurotransmitters regulate the migration and cytotoxicity in natural killer cells. Immunol Lett. 2003; 90(2-3):165-72. DOI: 10.1016/j.imlet.2003.09.004. View

18.

Sanger G . Neurokinin NK1 and NK3 receptors as targets for drugs to treat gastrointestinal motility disorders and pain. Br J Pharmacol. 2004; 141(8):1303-12. PMC: 1574901. DOI: 10.1038/sj.bjp.0705742. View

19.

Bar-Shavit Z, Goldman R, Stabinsky Y, Gottlieb P, Fridkin M, Teichberg V . Enhancement of phagocytosis - a newly found activity of substance P residing in its N-terminal tetrapeptide sequence. Biochem Biophys Res Commun. 1980; 94(4):1445-51. DOI: 10.1016/0006-291x(80)90581-1. View

20.

Evangelista S . Involvement of tachykinins in intestinal inflammation. Curr Pharm Des. 2001; 7(1):19-30. DOI: 10.2174/1381612013398446. View